<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Clinical Evidence | FMT in Gut-Related Diseases</title>
    <link rel="stylesheet" href="css/style.css">
    <style>
        html {
            scroll-behavior: smooth;
        }

        .evidence-container {
            max-width: 900px;
            margin: 0 auto;
            padding: 4rem 2rem;
        }

        .blog-section {
            margin-bottom: 5rem;
        }

        .blog-section h2 {
            font-size: 2.5rem;
            margin-bottom: 1.5rem;
            color: var(--navy);
            border-bottom: 2px solid var(--cyan);
            display: inline-block;
            padding-bottom: 0.5rem;
        }

        .blog-section h3 {
            font-size: 1.8rem;
            margin: 2.5rem 0 1rem;
            color: var(--navy);
        }

        .blog-section p {
            font-size: 1.1rem;
            line-height: 1.8;
            color: var(--text-main);
            margin-bottom: 1.5rem;
            text-align: justify;
        }

        .findings-box {
            background: var(--light-bg);
            padding: 2.5rem;
            border-radius: 15px;
            border-left: 5px solid var(--cyan);
            margin: 2rem 0;
        }

        .findings-box h4 {
            margin-bottom: 1rem;
            color: var(--navy);
            font-size: 1.2rem;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        .findings-box ul {
            list-style: none;
        }

        .findings-box li {
            margin-bottom: 0.8rem;
            padding-left: 1.5rem;
            position: relative;
        }

        .findings-box li::before {
            content: "•";
            color: var(--cyan);
            font-weight: bold;
            position: absolute;
            left: 0;
        }

        .summary-blockquote {
            background: rgba(31, 202, 211, 0.05);
            border-left: 4px solid var(--cyan);
            padding: 1.5rem 2rem;
            margin: 2rem 0;
            font-style: italic;
            color: var(--navy);
            font-weight: 500;
        }

        .references-section {
            background: #f8fbfc;
            padding: 5rem 2rem;
            border-top: 1px solid var(--border-color);
        }

        .reference-list {
            list-style: none;
            padding: 0;
        }

        .reference-item {
            margin-bottom: 2rem;
            font-size: 0.95rem;
            line-height: 1.6;
            padding-left: 2rem;
            position: relative;
        }

        .reference-item::before {
            content: attr(data-index);
            position: absolute;
            left: 0;
            color: var(--cyan);
            font-weight: bold;
        }

        .reference-item a {
            color: var(--cyan);
            text-decoration: none;
            font-weight: 500;
        }

        .reference-item a:hover {
            text-decoration: underline;
        }

        .hero-mini {
            position: relative;
            background: linear-gradient(rgba(11, 31, 51, 0.85), rgba(11, 31, 51, 0.85)), url('assets/images/evidence_bg.png');
            background-size: cover;
            background-position: center;
            color: white;
            padding: 160px 0 100px;
            text-align: center;
            margin-top: 0;
        }

        .hero-mini .tag {
            background: rgba(31, 202, 211, 0.2);
            color: var(--cyan);
            border: 1px solid rgba(31, 202, 211, 0.3);
            backdrop-filter: blur(5px);
            padding: 0.5rem 1.5rem;
            border-radius: 50px;
            font-weight: 600;
            letter-spacing: 1px;
            text-transform: uppercase;
            font-size: 0.85rem;
        }

        sup a {
            color: var(--cyan);
            text-decoration: none;
            font-weight: bold;
            padding: 0 2px;
        }

        sup a:hover {
            text-decoration: underline;
        }
    </style>
    <script src="js/script.js" defer></script>
</head>

<body class="bg-fafafa">
    <header class="site-header">
        <div class="container flex justify-between items-center">
            <a href="index.html" class="logo-container">
                <div class="logo">Jivanu<span>.</span></div>
                <div class="logo-tagline">Microbes to Medicine</div>
            </a>
            <nav class="flex items-center">
                <div class="nav-links flex items-center">
                    <a href="index.html">Home</a>
                    <a href="atlas.html">Jivanu Atlas™</a>
                    <a href="rebiome.html">ReBiome™</a>
                    <a href="novabiome.html">NovaBiome™</a>
                </div>
<button class="hamburger-menu" id="hamburger-menu" aria-label="Menu">
                    <span class="hamburger-line"></span>
                    <span class="hamburger-line"></span>
                    <span class="hamburger-line"></span>
                </button>

                <div class="mobile-menu-overlay" id="mobile-menu-overlay">                    <div class="mobile-signin-row">
                        <a href="signin.html" class="mobile-link signin-link">Sign In</a>
                        <label class="theme-switch compact">
                            <input type="checkbox" class="theme-toggle-input" data-theme-toggle aria-label="Toggle dark mode">
                            <span class="theme-slider"><span class="theme-knob"></span></span>
                        </label>
                    </div>
<div class="mobile-section-label mobile-only">Platforms</div>
                    <a href="atlas.html" class="mobile-link mobile-only">Jivanu Atlas™</a>
                    <a href="rebiome.html" class="mobile-link mobile-only">ReBiome™</a>
                    <a href="novabiome.html" class="mobile-link mobile-only">NovaBiome™</a>
                    <a href="team.html" class="mobile-link">Team</a>
                    <a href="careers.html" class="mobile-link">Careers</a>
                    <a href="contact.html" class="mobile-link">Contact</a>
                    <a href="evidence.html" class="mobile-link">Clinical Evidence</a>
                    <div class="mobile-divider"></div>
                                    <button class="mobile-logout" id="mobile-logout" type="button">Logout</button>
                </div>
            </nav>
        </div>
    </header>

    <main>
        <section class="hero-mini">
            <div class="container">
                <span class="tag">Scientific Education</span>
                <h1 style="color: white; font-size: 3.5rem; margin-top: 1.5rem; letter-spacing: -0.5px;">Clinical
                    Evidence: FMT in Gut-Related Diseases</h1>
                <p
                    style="color: rgba(255,255,255,0.9); max-width: 800px; margin: 2rem auto 0; font-size: 1.35rem; line-height: 1.6; font-weight: 300;">
                    Providing high transparency and science-driven insights into the therapeutic potential of the
                    microbiome.
                </p>
            </div>
        </section>

        <article class="evidence-container">
            <section class="blog-section">
                <h3>Overview</h3>
                <p>Fecal Microbiota Transplantation (FMT) is a microbiome-based approach designed to restore healthy gut
                    microbial balance. It has been examined across multiple clinical settings, showing the strongest
                    evidence in inflammatory and infectious gut diseases.</p>
            </section>

            <section class="blog-section">
                <h2>1. Ulcerative Colitis (UC)</h2>

                <h3>Real-World Evidence (India)</h3>
                <p>A prospective real-world analysis conducted at <strong>Dayanand Medical College & Hospital
                        (Ludhiana)</strong> involving steroid-dependent UC patients treated with repeated FMT sessions
                    via colonoscopy demonstrated significant outcomes:</p>
                <ul>
                    <li><strong>~46%</strong> achieved steroid-free clinical remission.</li>
                    <li><strong>~76%</strong> showed clinical response; <strong>~63%</strong> achieved endoscopic
                        remission at 24 weeks.</li>
                    <li>Responders successfully withdrew from steroids without serious adverse effects <sup
                            id="cite1"><a href="#ref1">[1]</a></sup>.</li>
                </ul>

                <h3>Multicenter Randomized Controlled Trial (India)</h3>
                <p>An open-label RCT involving leading institutions (AIIMS Delhi, PGIMER, Lisie, IMS BHU, Lokmanya
                    Tilak, and Dayanand) evaluated multi-donor FMT combined with an anti-inflammatory diet. The study
                    showed effective induction and maintenance of remission over one year when combined with standard
                    care <sup id="cite2"><a href="#ref2">[2]</a></sup>.</p>

                <h3>Global Evidence</h3>
                <p>Meta-analyses of multiple Randomized Controlled Trials (RCTs) confirm that FMT significantly
                    increases clinical and endoscopic remission rates compared to control groups, validating its
                    therapeutic potential globally <sup id="cite3"><a href="#ref3">[3]</a></sup>.</p>

                <div class="summary-blockquote">
                    <strong>Summary:</strong> Both controlled and real-world data support FMT’s role in inducing
                    remission in UC, with substantial clinical evidence contributed by major Indian medical centers.
                    </div>
            </section>

            <section class="blog-section">
                <h2>2. Recurrent Clostridioides difficile Infection (CDI)</h2>

                <h3>Tertiary Care Insights (India)</h3>
                <p>In high-risk cases, such as hematopoietic stem cell transplant (HSCT) recipients with refractory or
                    recurrent CDI, FMT administered at a tertiary center in India led to a complete resolution of
                    infection in the majority of patients with minimal unrelated adverse events <sup id="cite4"><a
                            href="#ref4">[4]</a></sup>.</p>

                <h3>Global Context</h3>
                <p>Systematic reviews consistently show that FMT provides a massive increase in resolution rates for
                    recurrent CDI compared to standard antibiotic therapy, maintaining high cure rates across
                    international studies <sup id="cite5"><a href="#ref5">[5]</a></sup>.</p>

                <div class="summary-blockquote">
                    <strong>Summary:</strong> FMT is highly effective in resolving recurrent CDI, even in
                    immunocompromised patients, aligning Indian clinical success with global benchmarks.
                    </div>
            </section>

            <section class="blog-section">
                <h2>3. Parkinson’s Disease (Gut–Brain Axis)</h2>
                <p>Emerging research into the gut–brain axis has led to clinical trials exploring FMT for Parkinson’s
                    Disease. Early pilot studies suggest that FMT is well-tolerated and can successfully shift gut
                    microbial profiles, with some patients reporting improvements in gastrointestinal symptoms like
                    constipation. However, evidence for direct neurologic benefit remains exploratory <sup id="cite6"><a
                            href="#ref6">[6]</a></sup>.</p>
            </section>

            <section class="blog-section">
                <h2>4. Autism Spectrum Disorder (ASD)</h2>

                <h3>International Research</h3>
                <p>FMT in ASD is being actively explored globally. Clinical trials assess safety and microbiome changes
                    in children, with some prospective studies showing improvements in both GI symptoms and core
                    behavioral symptoms without serious adverse events <sup id="cite7"><a href="#ref7">[7]</a></sup>.
                </p>

                <h3>Emerging Research in India</h3>
                <p>The <strong>Indian Council of Medical Research (ICMR)</strong> has approved FMT research for autistic
                    children at the Resplice Autism Institute in Hyderabad. This reflects the growing clinical interest
                    in microbiome influences on neurodevelopmental conditions in India <sup id="cite8"><a
                            href="#ref8">[8]</a></sup>.</p>
            </section>
        </article>

        <section class="references-section" id="references">
            <div class="container">
                <h2 style="margin-bottom: 3rem; color: var(--navy);">References</h2>
                <ul class="reference-list">
                    <li class="reference-item" id="ref1" data-index="1.">
                        <strong>Sood A, Mahajan R, et al.</strong> Efficacy of fecal microbiota therapy in steroid
                        dependent ulcerative colitis. <em>Dayanand Medical College & Hospital.</em>
                        <a href="https://pubmed.ncbi.nlm.nih.gov/30449078/" target="_blank">PMID: 30449078</a>
                    </li>
                    <li class="reference-item" id="ref2" data-index="2.">
                        <strong>Clinical Trial Protocol.</strong> Effect of fecal transplant and dietary changes on
                        newly diagnosed active ulcerative colitis. <em>Multicenter India.</em>
                        <a href="https://www.centerwatch.com/clinical-trials/listings/NCT06895252/"
                            target="_blank">NCT06895252</a>
                    </li>
                    <li class="reference-item" id="ref3" data-index="3.">
                        <strong>Costello SP, et al.</strong> Systematic review and meta-analysis of FMT for induction of
                        remission in UC.
                        <a href="https://pubmed.ncbi.nlm.nih.gov/35965832/" target="_blank">PMID: 35965832</a>
                    </li>
                    <li class="reference-item" id="ref4" data-index="4.">
                        <strong>Prayag PS, Patwardhan SA, et al.</strong> FMT for CDI in hematopoietic stem cell
                        transplant recipients: Indian tertiary center experience.
                        <a href="https://pubmed.ncbi.nlm.nih.gov/38323255/" target="_blank">PMID: 38323255</a>
                    </li>
                    <li class="reference-item" id="ref5" data-index="5.">
                        <strong>Global Systematic Review.</strong> Resolution of Recurrent Clostridioides difficile
                        Infection following FMT. (Generic reference based on provided text context).
                    </li>
                    <li class="reference-item" id="ref6" data-index="6.">
                        <strong>Pilot RCT.</strong> Safety and microbiome changes in Parkinson’s disease.
                        <a href="https://pubmed.ncbi.nlm.nih.gov/36937520/" target="_blank">PMID: 36937520</a>
                    </li>
                    <li class="reference-item" id="ref7" data-index="7.">
                        <strong>Li Y, et al.</strong> FMT in children with autism spectrum disorder: GI and core symptom
                        improvements.
                        <a href="https://pubmed.ncbi.nlm.nih.gov/39677507/" target="_blank">PMID: 39677507</a>
                    </li>
                    <li class="reference-item" id="ref8" data-index="8.">
                        <strong>News Report.</strong> ICMR nod for FMT trial on autistic children in Hyderabad.
                        <a href="https://timesofindia.indiatimes.com/city/hyderabad/hyds-institute-gets-icmr-nod-for-fmt-trial-on-autistic-kids/articleshow/124881223.cms"
                            target="_blank">Times of India</a>
                    </li>
                </ul>
            </div>
        </section>

        <section class="section" style="background: var(--navy); color: white; text-align: center;">
            <div class="container">
                <h2 style="color: white; margin-bottom: 2rem;">Collaborate with Jivanu</h2>
                <p style="margin-bottom: 3rem; opacity: 0.9;">We are focused on translating this evidence into
                    standardized microbial therapies.</p>
                <a href="contact.html" class="btn btn-primary"
                    style="background: var(--cyan); border-color: var(--cyan); color: var(--navy); font-weight: 700;">Get
                    In Touch</a>
            </div>
        </section>
    </main>

    <footer>
        <div class="container">
            <div class="grid footer-grid">
                <div>
                    <a href="index.html" class="footer-logo-link"><img src="assets/images/Jivanu_Logo.png" alt="Jivanu Logo"
                        style="max-width: 280px; margin-bottom: 1.5rem;"></a>
                    </div>
                <!-- ... footer links (same as before) ... -->
                <div class="footer-links">
                    <h4>Platforms</h4>
                    <ul>
                        <li><a href="atlas.html">Jivanu Atlas™</a></li>
                        <li><a href="rebiome.html">ReBiome™</a></li>
                        <li><a href="novabiome.html">NovaBiome™</a></li>
                    </ul>
                    </div>
                <div class="footer-links">
                    <h4>Company</h4>
                    <ul>
                        <li><a href="team.html">Team</a></li>
                        <li><a href="careers.html">Careers</a></li>
                        <li><a href="contact.html">Contact</a></li>
                    </ul>
                    </div>
                <div class="footer-links">
                    <h4>Legal</h4>
                    <ul>
                        <li><a href="privacy.html">Privacy Policy</a></li>
                        <li><a href="terms.html">Terms of Service</a></li>
                        <li><a href="refund.html">Refund Policy</a></li>
                    </ul>
                    </div>
            </div>
            <div class="footer-bottom">
                <p>© 2026 Jivanu Therapeutics Pvt Ltd. All rights reserved.</p>
            </div>
        </div>
    </footer>
</body>

</html>
